Latest Operational Milestones News

Native Mineral Resources (ASX:NMR) hit a new monthly gold production record of 1,080.5oz in August 2026 at its Blackjack operation, driven by a 50% rise in milling throughput and a 27% increase in head grade.

Medallion Metals has awarded a $50 million EPC contract to GR Engineering to convert its Cosmic Boy Concentrator into a standalone facility producing copper concentrate and gold doré, aligning with feasibility estimates and advancing production timelines.

Peppermint Innovation Limited posted a $2.4 million net loss for FY26 as it shifted from platform development to commercial execution in the Philippines, achieving key regulatory milestones and securing strategic investment.

Ceretas Limited posted a $1.63 million net loss for FY26 on $1.28 million revenue from government grants, advancing its clinical-stage Alzheimer’s ultrasound platform. The company completed an $8 million IPO in July to fund pivotal trials and device development.

Liontown Limited (ASX:LTR) has reported its maiden profit and strong cash flow in FY26, completing its transition to fully underground mining at Kathleen Valley and advancing expansion plans with a final investment decision due early FY27.

Elixir Energy has marked FY26 with major progress in Queensland’s Taroom Trough, expanding contingent gas resources by 32% and securing a strategic $16.6 million capital raise led by Omega Oil and Gas. The company’s operational advances and government backing position it as a key player in Australia’s energy security landscape.

Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.

D3 Energy has successfully cased and cemented two wells at its Nooitgedacht project in South Africa, detecting gas in both despite challenging reservoir conditions. Testing awaits reservoir pressure normalization.

Lynas Rare Earths delivered a record A$977.9 million revenue and A$222.4 million net profit in FY26, underpinned by strong rare earth production, strategic supply agreements, and a 10-year Malaysian licence renewal.

Radiopharm Theranostics has dosed the first patient in the second cohort of its Phase 1/2a trial for RV-01, a radiopharmaceutical targeting B7-H3 expressing solid tumors, marking a key dose escalation milestone.

Sinclair Gold has cleared a key drilling milestone at its Mt Henry project, prompting a $5 million cash payment to Westgold and cancelling over 7.5 million performance rights. The company also moves closer to completing a royalty deal with Stria Lithium, while preparing for a resource update by year-end.

Manuka Resources has recommenced gold processing at its Wonawinta facility using stockpiled Mt Boppy ore following a five-month upgrade program. Silver production is set to begin in the final quarter of 2026 after further plant enhancements.